Nektar Therapeutics

Simbol: 0UNL.L

LSE

1.65

USD

Tržna cena danes

  • -1.1419

    Razmerje P/E

  • 0.0069

    Razmerje PEG

  • 302.98M

    Kapaciteta MRK

  • 0.00%

    Donos DIV

Nektar Therapeutics (0UNL-L) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za Nektar Therapeutics (0UNL.L). Prihodki podjetja prikazujejo povprečje NaN M, ki je NaN % gowth. Povprečni bruto dobiček za celotno obdobje je NaN M, ki je NaN %. Povprečno razmerje bruto dobička je NaN %. Rast čistega dobička za lanskoletno poslovanje podjetja je NaN %, kar je enako NaN % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja Nektar Therapeutics, opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na . Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini NaN. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo NaN v valuti poročanja. Letna sprememba tega vidika je NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012

balance-sheet.row.cash-and-short-term-investments

0303.6505734
1061.9
1324.9
1335.3
296.1
389.1
308.9
237.8
237
277.2

balance-sheet.row.short-term-investments

0283.5438.1719.7
872.6
1235.5
1140.4
291.4
329.5
253.4
225.5
198
251.8

balance-sheet.row.net-receivables

02.3623.9
44
36.8
43.2
5
15.7
19.9
3.6
2.2
5.8

balance-sheet.row.inventory

016.119.215.8
19.2
44.5
11.4
10.7
11.1
11.3
13
13.5
18.3

balance-sheet.row.other-current-assets

08.715.821.9
12.9
15.4
47.7
14.9
10.1
9.8
33.8
5.2
13.4

balance-sheet.row.total-current-assets

0330.7546795.6
1138
1421.5
1437.7
326.8
426
350.1
288.2
257.9
314.6

balance-sheet.row.property-plant-equipment-net

036.985.9177.5
186.1
199.2
48.9
47.5
65.6
71.3
70.4
67
72.2

balance-sheet.row.goodwill

0076.576.5
76.5
76.5
76.5
76.5
76.5
76.5
76.5
76.5
76.5

balance-sheet.row.intangible-assets

0000
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0076.576.5
76.5
76.5
76.5
76.5
76.5
76.5
76.5
76.5
76.5

balance-sheet.row.long-term-investments

025.8064.8
136.7
279.1
582.9
57.1
0
0
0
0
0

balance-sheet.row.tax-assets

0000
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

04.62.22.7
1.5
1
-708.2
-181.1
-142.1
-147.8
-146.9
-143.5
-148.7

balance-sheet.row.total-non-current-assets

067.3164.6321.6
400.8
555.8
708.2
181.1
142.1
147.8
146.9
143.5
148.7

balance-sheet.row.other-assets

0000
0
0
4.2
1
0.8
0.8
6.6
33.2
34.4

balance-sheet.row.total-assets

0398710.61117.2
1538.8
1977.4
2150.2
508.9
568.9
498.6
441.6
434.5
497.8

balance-sheet.row.account-payables

09.8139.7
22.1
19.2
5.9
4.8
2.8
2.4
2.7
9.1
2.9

balance-sheet.row.short-term-debt

019.318.717.4
13.9
261.2
0
0
0
0
0
0
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0112.6126.5148.1
170.1
47
246.9
245.2
243.5
241.7
125
125
125

Deferred Revenue Non Current

0000
2.5
2.6
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

022.236.658
79.6
67.9
76.1
51.4
69.4
58.9
61.3
89.1
75.7

balance-sheet.row.total-non-current-liabilities

0215.8275.8352.5
345.7
218.1
246.9
245.2
243.5
241.7
125
125
125

balance-sheet.row.other-liabilities

0000
0
0
103.6
119.7
165.1
189.3
216.2
301.2
247.2

balance-sheet.row.capital-lease-obligations

098.5112.8125.7
136.4
142.7
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0267344437.7
461.5
572
432.6
421
480.7
492.2
405.3
524.4
450.8

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0000
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

0-3477.2-3201.2-2833
-2309.2
-1864.7
-1424.1
-2117.9
-2021
-1867.5
-1786.3
-1732.4
-1570.4

balance-sheet.row.accumulated-other-comprehensive-income-loss

00.1-6.9-4.2
-2.3
-1
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

03608.13574.73516.6
3388.7
3271.1
3141.6
2205.8
2109.1
1873.9
1822.6
1642.5
1617.4

balance-sheet.row.total-stockholders-equity

0131366.6679.5
1077.3
1405.4
1717.6
87.8
88.1
6.4
36.3
-89.9
47

balance-sheet.row.total-liabilities-and-stockholders-equity

0398710.61117.2
1538.8
1977.4
0
0
0
0
0
0
0

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

0131366.6679.5
1077.3
1405.4
1717.6
87.8
88.1
6.4
36.3
-89.9
47

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-

Total Investments

0309.3438.1784.5
1009.2
1514.6
1723.3
348.5
329.5
253.4
225.5
198
251.8

balance-sheet.row.total-debt

0230.4258291.3
320.4
450.9
0
0
0
0
0
0
0

balance-sheet.row.net-debt

0210.2191.1277
131
361.5
-194.9
-4.8
-59.6
-55.6
-12.4
-39.1
-25.4

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Nektar Therapeutics opazno spremenil prosti denarni tok, ki se je spremenil v NaN. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo NaN, kar kaže na razliko NaN v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini NaN v valuti poročanja. To je premik za NaN v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila NaN, NaN in NaN, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila NaN, pri čemer je razlika v primerjavi z letom prej znašala NaN. Poleg tega je podjetje namenilo NaN za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane NaN, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012

cash-flows.row.net-income

0-276.1-368.2-523.8
-444.4
-440.7
681.3
-96.7
-153.5
-81.2
-53.9
-162
-171.9

cash-flows.row.depreciation-and-amortization

07.812.213
12.5
11
10.9
14.7
15.4
12.9
12.9
14.3
14.5

cash-flows.row.deferred-income-tax

0-0.12.7-106.6
-93.5
-104.9
-61.9
-47.7
-30.4
-4.9
-16.1
-26.1
-9.7

cash-flows.row.stock-based-compensation

0-1357.394.7
94.3
99.8
88.1
36.6
25.9
19.7
17
17.7
16.2

cash-flows.row.change-in-working-capital

0-19.80.5-23.1
16.7
21.7
-26.2
11
4.5
-14.7
-0.9
8.4
-6.5

cash-flows.row.account-receivables

04.816.512.4
1.9
6.4
-25.5
10.7
4.3
-16.3
-1.4
3.6
-0.9

cash-flows.row.inventory

00.7-3.4-0.5
-2.6
-1.3
-0.7
0.4
0.2
1.6
0.5
4.8
-5.6

cash-flows.row.account-payables

0-2.93.1-11.7
2.4
13
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-22.4-15.7-23.3
15
3.6
0
0
0
0
0
0
0

cash-flows.row.other-non-cash-items

0108.6-8.5133.1
101.2
84.4
26
-46.1
-9.2
-9.7
-117.2
83.1
17.9

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-0.9-5.7-15
-7.3
-26.3
-14.2
-9.7
-6.4
-11.2
-10
-4.1
-10.6

cash-flows.row.acquisitions-net

01.213.2-217.8
-503.5
-233.2
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0-511.7-467.9-960.7
-987.5
-1380.9
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0650.9826.21178.5
1491
1614
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

000217.8
503.5
233.2
-1365.7
-19.1
-76
-3.1
-27.6
54
123.6

cash-flows.row.net-cash-used-for-investing-activites

0139.6365.8202.8
496.2
206.9
-1379.9
-28.8
-82.4
-14.3
-37.6
49.9
113

cash-flows.row.debt-repayment

0000
-103.8
0
0
-5.1
-5.9
-130.2
-3.5
-3
-174.8

cash-flows.row.common-stock-issued

000.833.2
23.4
23.4
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

000.83
-80.4
23.4
852
59.5
209.6
261
156.5
5.2
201.6

cash-flows.row.net-cash-used-provided-by-financing-activities

001.536.2
-80.4
23.4
852
54.4
203.6
130.8
153
2.2
26.8

cash-flows.row.effect-of-forex-changes-on-cash

06.3-0.3-0.1
0
-0.1
-0.1
0
-0.1
-0.2
-0.1
0
0.1

cash-flows.row.net-change-in-cash

0-46.752.5-175.1
99.9
-105.5
190.1
-54.9
4.1
43.2
-26.7
13.6
10.1

cash-flows.row.cash-at-end-of-period

020.266.814.3
189.3
89.4
194.9
4.8
59.6
55.6
12.4
39.1
25.4

cash-flows.row.cash-at-beginning-of-period

066.814.3189.3
89.4
194.9
4.8
59.6
55.6
12.4
39.1
25.4
15.3

cash-flows.row.operating-cash-flow

0-192.6-304-412.7
-313.3
-328.7
718.2
-80.4
-117
-73.1
-142
-38.5
-129.8

cash-flows.row.capital-expenditure

0-0.9-5.7-15
-7.3
-26.3
-14.2
-9.7
-6.4
-11.2
-10
-4.1
-10.6

cash-flows.row.free-cash-flow

0-193.5-309.7-427.6
-320.5
-355
704
-90.1
-123.4
-84.3
-152
-42.6
-140.3

Vrstica izkaza poslovnega izida

Prihodki Nektar Therapeutics so se v primerjavi s prejšnjim obdobjem spremenili za NaN%. Bruto dobiček podjetja 0UNL.L znaša NaN. Odhodki iz poslovanja podjetja so NaN in so se v primerjavi s prejšnjim letom spremenili za NaN%. Odhodki za amortizacijo znašajo NaN, kar je NaN% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini NaN, ki kaže NaN% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo NaN, kar pomeni NaN% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša NaN in predstavlja NaN% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so NaN, ki kažejo NaN% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je NaN%. Čisti prihodki v zadnjem letu so znašali NaN.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012

income-statement-row.row.total-revenue

090.192.1101.9
152.9
114.6
1193.3
307.7
165.4
230.8
200.7
148.9
81.2

income-statement-row.row.cost-of-revenue

036.629.134.7
28.7
29.5
24.4
30.5
30.2
34.1
28.5
38.5
30.4

income-statement-row.row.gross-profit

053.562.967.2
124.2
85.1
1168.9
277.2
135.2
196.7
172.2
110.4
50.8

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0000
0
0
0
0
0
0
0
0
0

income-statement-row.row.operating-expenses

0190.9303.2513.3
504.1
525.1
481
336.8
248.1
240.1
188.7
230.5
192

income-statement-row.row.cost-and-expenses

0227.5332.3548
532.8
554.7
505.4
367.4
278.3
274.2
217.2
269.1
222.4

income-statement-row.row.interest-income

01922.244.7
18.8
0
5.2
36.4
39.8
37.2
37.9
39.6
30.2

income-statement-row.row.interest-expense

025.328.947.3
37.1
46.4
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-138.8-124.7-77.2
-64
0
-5.2
-52.4
-39.8
-51.3
-37.9
-39.6
-31.9

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0000
0
0
0
0
0
0
0
0
0

income-statement-row.row.total-operating-expenses

0-138.8-124.7-77.2
-64
0
-5.2
-52.4
-39.8
-51.3
-37.9
-39.6
-31.9

income-statement-row.row.interest-expense

025.328.947.3
37.1
46.4
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

07.812.213
12.5
11
10.9
14.7
15.4
12.9
12.9
14.3
14.5

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-137.4-240.2-446.1
-379.9
-440
687.9
-43.7
-112.9
-29.4
-16.5
-120.1
-139.5

income-statement-row.row.income-before-tax

0-276.3-365-523.3
-443.9
-440.1
682.7
-96.1
-152.6
-80.7
-54.4
-159.8
-171.4

income-statement-row.row.income-tax-expense

0-0.23.20.6
0.5
0.6
1.4
0.6
0.9
0.5
0.5
2.2
0.4

income-statement-row.row.net-income

0-276.1-368.2-523.8
-444.4
-440.7
681.3
-96.7
-153.5
-81.2
-53.9
-162
-171.9

Pogosto zastavljeno vprašanje

Kaj je Nektar Therapeutics (0UNL.L) skupna sredstva?

Nektar Therapeutics (0UNL.L) skupna sredstva so 398033000.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so N/A.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.625.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je -1.013.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je -3.063.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so -1.500.

Kaj je Nektar Therapeutics (0UNL.L) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je -276056000.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 230401000.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 190903000.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 0.000.